Clinical Trials on Colitis, Lymphocytic

Total 3739 results

Mayo Clinic

Completed

UC Cohort - The Influence of Diet on Gut Microbiotas

Ulcerative Colitis

United States
Innovo Therapeutics, Inc.

Completed

First in Human, Single Ascending Dose Study

Ulcerative Colitis

Korea, Republic of
Bridge Biotherapeutics, Inc.
KCRN Research, LLC

Completed

First-In-Human Study of BBT-401-1S Following Single and Multiple Ascending Doses in Healthy Volunteers

Ulcerative Colitis

United States
Roxane Laboratories

Completed

A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Balsalazide Disodium 750 mg Capsules Under Fasting Conditions

Ulcerative Colitis

United States
Roxane Laboratories

Completed

Bioequivalency Study of Balsalazide Capsules Under Fasting Conditions

Ulcerative Colitis

United States
University of Arkansas
Janssen Scientific Affairs, LLC

Withdrawn

Predicting Clinical Response to Golimumab With Mucosal Barrier Dysfunction

Ulcerative Colitis
Tillotts Pharma AG

Completed

TP0501 - Pharmaco-Scintigraphic-Study

Ulcerative Colitis
Clinical Hospital Center, Split

Unknown

Importance of CD4+CD25+ly in UC1. Investigation of Difference Between Blood Concentration IL 17, IL 33, Regulatory T ly in Patients With UC and Control Group

Ulcerative Colitis

Croatia
Paolo Caimi, MD
National Cancer Institute (NCI)

Completed

Curcumin and Cholecalciferol in Treating Patients With Previously Untreated Stage 0-II Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Stage 0 Chronic Lymphocytic Leukemia | Stage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Contiguous Stage II Small Lymphocytic Lymphoma | Noncontiguous Stage II Small Lymphocytic Lymphoma | Stage I Small Lymphocytic Lymphoma

United States
Roswell Park Cancer Institute
National Cancer Institute (NCI); Celgene Corporation

Terminated

Lenalidomide as Chemoprevention in Treating Patients With High-Risk, Early-Stage B-Cell Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia | B-cell Chronic Lymphocytic Leukemia | Stage 0 Chronic Lymphocytic Leukemia | Stage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia

United States
Fondazione Policlinico Universitario Agostino Gemelli...

Recruiting

Superdonor FMT in Patients With Ulcerative Colitis

Active Ulcerative Colitis

Italy
Centre Hospitalier Universitaire de Saint Etienne
Ministry of Health, France

Terminated

Impact of Anti-cytomegalovirus Treatment in the Management of Relapsing Ulcerative Colitis Requiring Vedolizumab Therapy (CYTOVEDO)

Ulcerative Colitis, Unspecified

France
AbbVie

Active, not recruiting

A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Participants With Ulcerative Colitis (UC)

Ulcerative Colitis (UC)

United States, Argentina, Australia, Austria, Belarus, Belgium, Bosnia and Herzegovina, Brazil, Canada, Chile, China, Colombia, Croatia, Czechia, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Japan, Korea, Republic... and more
AbbVie

Active, not recruiting

Assessing Effectiveness of Adalimumab for Treating Ulcerative Colitis in Real Life Conditions (SOTHIS)

Ulcerative Colitis (UC)

France
Theravance Biopharma

Terminated

TD-1473 Long-Term Safety (LTS) Ulcerative Colitis (UC) Study

Ulcerative Colitis (UC)

United States, Australia, Bulgaria, Canada, France, Georgia, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Poland, Portugal, Romania, Serbia, Slovakia, South Africa, Spain, Taiwan, Ukraine
AbbVie

Completed

A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Ulcerative Colitis (U-Accomplish)

Ulcerative Colitis (UC)

United States, Argentina, Australia, Austria, Belgium, Bosnia and Herzegovina, Brazil, Canada, Chile, China, Colombia, Croatia, Czechia, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic... and more
Nantes University Hospital

Completed

Evaluation of Sacral Neuromodulation (SNM) in the Treatment of Active Ulcerative Colitis (PRIMICISTIM) (PRIMICISTIM)

Active Ulcerative Colitis

France
Xijing Hospital of Digestive Diseases
Shanghai Tongji Hospital, Tongji University School of Medicine; First Affiliated...

Unknown

Mesalazine With Hydrocortisone Sodium Succinate Enema for 4-Week Treatment in Patients With Ulcerative Colitis

Ulcerative Colitis, Unspecified

China
Prof. Arie Levine

Terminated

Use of the Ulcerative Colitis Diet for Induction of Remission

Ulcerative Colitis (UC)

Israel
The Leeds Teaching Hospitals NHS Trust

Unknown

Utilization of NBi in Assessing Luminal INflammaion in IBD (UNBLIND)

Ulcerative Colitis (UC)

United Kingdom
Facet Biotech
PDL BioPharma, Inc.

Completed

Ulcerative Colitis Study: Study of Visilizumab in Patients With Severe Ulcerative Colitis

Severe Ulcerative Colitis

United States
Postgraduate Institute of Medical Education and...

Completed

Antibiotics as an Adjuvant in Patients With Acute Severe Ulcerative Colitis (AAASUC)

Inflammatory Bowel Diseases | Ulcerative Colitis | Acute Severe Colitis

India
St Vincent's Hospital Melbourne

Unknown

FMT in Inflammatory Bowel Disease

Crohn Disease | Ulcerative Colitis | Microscopic Colitis | Faecal Microbiota Transplantation

Australia
National Cancer Institute (NCI)

Active, not recruiting

Lenalidomide and Vaccine Therapy in Treating Patients With Early-Stage Asymptomatic Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Stage 0 Chronic Lymphocytic Leukemia | Stage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Ann Arbor Stage I Small Lymphocytic Lymphoma | Ann Arbor Stage II Small Lymphocytic Lymphoma | Chronic Lymphocytic Leukemia... and other conditions

United States
Ganzhou Hemay Pharmaceutical Co., Ltd

Recruiting

Phase II Study of Hemay005 in Patients With Active Ulcerative Colitis

Moderate to Severe Ulcerative Colitis

China
Assiut University

Not yet recruiting

Budesonide Multimatrix(MMX) Versus Prednisolone in Management of Mild to Moderate Ulcerative Colitis

Ulcerative Colitis Chronic
Sixth Affiliated Hospital, Sun Yat-sen University

Recruiting

A Cohort Study Comparing IFX to CS for Moderate to Severe UC (INSURE)

Moderate to Severe Ulcerative Colitis

China
ProgenaBiome

Recruiting

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Ulcerative Colitis

Ulcerative Colitis | Ulcerative Colitis Chronic

United States
Hull University Teaching Hospitals NHS Trust

Recruiting

Multi-centre Acute Severe Ulcerative Colitis Prospective Cohort Study (Elevate ASUC) (ELEVATE-ASUC)

Severe Ulcerative Colitis

United Kingdom
Beth Israel Deaconess Medical Center

Enrolling by invitation

High Definition Colonoscopy (HDC) vs. Dye Spraying Chromo-colonoscopy (DSC) in Screening Patients With Long-standing Inflammatory Bowel Disease (IBD)

Inflammatory Bowel Diseases | Ulcerative Colitis | Crohn Colitis | Indeterminate Colitis | Colon Dysplasia

United States
Suzhou Connect Biopharmaceuticals, Ltd.

Completed

A Study Assessing the Efficacy and Safety of CBP-307 in Subjects With Moderate to Severe Ulcerative Colitis (UC)

Moderate to Severe Ulcerative Colitis

United States, China, Pakistan, Ukraine
Tampere University Hospital

Completed

Efficacy of Cyclosporine Rescue Therapy in Acute Ulcerative Colitis. (Cyclo)

Ulcerative Colitis Acute
Schneider Children's Medical Center, Israel

Withdrawn

Curcumin in Pediatric Ulcerative Colitis

Ulcerative Colitis

Israel
Children's Hospital Medical Center, Cincinnati

Completed

Trial of a Decision Support Intervention for Adolescents and Young Adults With Ulcerative Colitis (iBDecide)

Ulcerative Colitis, Pediatric

United States
ReveraGen BioPharma, Inc.

Withdrawn

Proof of Concept Trial of Vamorolone in Pediatric Ulcerative Colitis

Pediatric Ulcerative Colitis
Mitsubishi Tanabe Pharma Corporation

Completed

Clinical Study of TA-650 in Pediatric Patients With Ulcerative Colitis

Pediatric Ulcerative Colitis

Japan
Tillotts Pharma AG

Completed

TP05 for the Treatment of Mild to Moderate Active Ulcerative Colitis (UC) (Precision-UC)

Acute Ulcerative Colitis

Switzerland
Sigmoid Pharma

Completed

Oral Ciclosporin for Colonic Release in Ulcerative Colitis (CyCol™)

Mild to Moderate Ulcerative Colitis

United Kingdom, Ireland
EMET Pharmaceuticals, LLC
Eagle Pharmaceuticals, Inc.

Completed

A BE Study Comparing Mesalamine 400 mg to ASACOL® 400 mg in Patients With Mild To Moderately Active Ulcerative Colitis

Mild to Moderate Ulcerative Colitis
Facet Biotech
PDL BioPharma, Inc.

Withdrawn

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis

Intravenous Steroid-Refractory Ulcerative Colitis
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Ruxolitinib Phosphate in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Untreated Chronic Lymphocytic Leukemia

United States
Showa Inan General Hospital

Recruiting

Association Between LRG and Endoscopic Remission in Ulcerative Colitis

Ulcerative Colitis in Remission

Japan
University of Edinburgh
JP Moulton Charitable Foundation; MitoQ

Not yet recruiting

MARVEL: Mitochondrial Anti-oxidant Therapy to Resolve Inflammation in Ulcerative Colitis (MARVEL)

Ulcerative Colitis Flare
University of Vermont

Unknown

Fecal Microbiota Transplant in the Treatment of Ulcerative Colitis (FMTUC)

Ulcerative Colitis, Active Moderate

United States
Otsuka Pharmaceutical Europe Ltd

Completed

Adacolumn in Refractory UC Patients Trial (ART)

Ulcerative Colitis, Active Moderate

France
Tillotts Pharma AG
Zeria Pharmaceutical

Completed

Comparative Efficacy and Safety Study in Patients With Ulcerative Colitis in Remission Phase

Ulcerative Colitis in Remission

China
ActoGeniX N.V.

Completed

A Phase 2a Study to Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of AG011 in Ulcerative Colitis

Moderately Active Ulcerative Colitis

Canada, Netherlands, Sweden, Belgium
National Heart, Lung, and Blood Institute (NHLBI)

Active, not recruiting

Ibrutinib, Fludarabine, and Pembrolizumab in High-Risk or Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Leukemia, Lymphocytic, Chronic, B-Cell | Chronic Lymphocytic Leukemia | Leukemia, Chronic Lymphatic | B-Cell Chronic Lymphocytic Leukemia | Leukemia, Lymphocytic, Chronic | B-Lymphocytic Leukemia, Chronic | Leukemia, Chronic Lymphocytic, B-Cell | Lymphocytic Leukemia, Chronic, B Cell | Lymphocytic Leukemia...

United States
BeiGene

Recruiting

Study of BGB-11417 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Lymphoma | Leukemia | Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Relapsed Chronic Lymphocytic Leukemia

China
Roswell Park Cancer Institute

Withdrawn

Azadirachta Indica in Treating Patients With Chronic Lymphocytic Leukemia

Refractory Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic Leukemia

Clinical Trials on Colitis, Lymphocytic

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in France

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations